RMC tumor cells undergo distinct transcriptional reconfiguration by engaging interferon gamma receptor 1 (IFNGR1) signaling following combination ICT, leading to the activation of myeloid-affiliated transcriptional circuits mediated by the CEBPB / p300 complex that can promote cell proliferation, resulting in hyperprogression. This evidence concerns the gene IFNGR1 and neoplasm.